{"name":"Dextroamphetamine","slug":"dextroamphetamine","kind":"substance","abbreviations":[],"systematic":null,"aliases":["D-Amphetamine","Dexamphetamine","Dexamfetamine","(S)-Amphetamine","Dexadrine","(+)-Amphetamine","(+)-(S)-Amphetamine","Dexidrine","(S)-(+)-Amphetamine","(S)-1-Phenyl-2-aminopropane"],"brands":[],"scraped":true,"has_structure":true,"cid":5826,"classes":[{"name":"stimulant","href":"/class/stimulant"}],"families":[{"name":"amphetamine","href":"/substituted/amphetamine"}],"physical":[{"label":"Molecular mass","value":"135.21 g/mol","copyable":false},{"label":"Appearance","value":"Colorless liquid","copyable":false},{"label":"Density","value":"0.949 g/cu cm at 15 °C","copyable":false},{"label":"Melting point","value":"-98","copyable":false},{"label":"Boiling point","value":"64.7","copyable":false},{"label":"Decomposition","value":"When heated to decomposition it emits toxic nitroxides.","copyable":false},{"label":"Solubility","value":"Moderately Soluble","copyable":false},{"label":"Predicted LogP","value":"1.8","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>9</sub>H<sub>13</sub>N","copyable":true},{"label":"IUPAC name","value":"(2S)-1-phenylpropan-2-amine","copyable":true},{"label":"SMILES","value":"C[C@@H](CC1=CC=CC=C1)N","copyable":true},{"label":"InChI","value":"InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3/t8-/m0/s1","copyable":true},{"label":"InChIKey","value":"KWTSXDURSIMDCE-QMMMGPOBSA-N","copyable":true},{"label":"CAS number","value":"51-64-9","copyable":true},{"label":"UNII","value":"TZ47U051FI","copyable":true},{"label":"PubChem CID","value":"5826","copyable":true}],"pharmacokinetics":[{"label":"Onset","value":"Immediate release dosing: 30–45 minutes<a href=\"#cite_note-3\"><sup>[3]</sup></a>","copyable":false},{"label":"Elimination half-life","value":"9–11 hours, pH-dependent: 7–34 hours<a href=\"#cite_note-4\"><sup>[4]</sup></a>","copyable":false},{"label":"Duration of action","value":"Immediate release dosing: 3–6 hours, Extended release dosing: 8–12 hours<a href=\"#cite_note-5\"><sup>[5]</sup></a><a href=\"#cite_note-6\"><sup>[6]</sup></a>","copyable":false},{"label":"Metabolism","value":"CYP2D6, DBH, FMO3<a href=\"#cite_note-7\"><sup>[7]</sup></a>","copyable":false},{"label":"Excretion","value":"Kidney (45%); urinary pH-dependent<a href=\"#cite_note-8\"><sup>[8]</sup></a>","copyable":false},{"label":"Routes of administration","value":"By mouth, transdermal, intravenous, insufflation, rectal","copyable":false},{"label":"Dependence liability","value":"Physical: None, Psychological: Moderate","copyable":false},{"label":"Addiction liability","value":"Moderate","copyable":false}],"toxicity":[{"kind":"LD50","organisms":[["Mouse",[{"kind":"LD50","organism":"Mouse","route":"oral","dose":"40 mg/kg"}]],["Rat",[{"kind":"LD50","organism":"Rat","route":"oral","dose":"96.8 mg/kg"},{"kind":"LD50","organism":"Rat","route":"oral","dose":"38 mg/kg"},{"kind":"LD50","organism":"Rat","route":"sc","dose":"200 mg/kg"},{"kind":"LD50","organism":"rat","route":"oral","dose":"96.8 mg/kg"}]]]}],"dosing":{"provider":"DBI-IGS (archived by anodyne.wiki)","routes":[{"method":"Insufflated","tiers":{"Common":{"lower":7.1,"upper":10.0,"unit":"mg","entries":0,"percentage":0.0},"Extreme":{"lower":15.0,"upper":15.0,"unit":"mg","entries":0,"percentage":0.0},"Heavy":{"lower":15.0,"upper":15.0,"unit":"mg","entries":0,"percentage":0.0},"Light":{"lower":7.1,"upper":7.1,"unit":"mg","entries":2,"percentage":50.0},"Strong":{"lower":10.0,"upper":15.0,"unit":"mg","entries":2,"percentage":50.0}}},{"method":"Sublingual","tiers":{"Common":{"lower":3.3,"upper":5.0,"unit":"mg","entries":26,"percentage":54.2},"Extreme":{"lower":5.0,"upper":5.0,"unit":"mg","entries":2,"percentage":4.2},"Heavy":{"lower":5.0,"upper":5.0,"unit":"mg","entries":0,"percentage":0.0},"Light":{"lower":3.3,"upper":3.3,"unit":"mg","entries":20,"percentage":41.7},"Strong":{"lower":5.0,"upper":5.0,"unit":"mg","entries":0,"percentage":0.0}}},{"method":"Oral","tiers":{"Common":{"lower":5.0,"upper":10.0,"unit":"mg","entries":136,"percentage":43.3},"Extreme":{"lower":10.0,"upper":10.0,"unit":"mg","entries":22,"percentage":7.0},"Heavy":{"lower":10.0,"upper":10.0,"unit":"mg","entries":0,"percentage":0.0},"Light":{"lower":5.0,"upper":5.0,"unit":"mg","entries":156,"percentage":49.7},"Strong":{"lower":10.0,"upper":10.0,"unit":"mg","entries":0,"percentage":0.0}}},{"method":"Intrarectal","tiers":{"Common":{"lower":30.9,"upper":30.0,"unit":"mg","entries":0,"percentage":0.0},"Extreme":{"lower":46.0,"upper":46.0,"unit":"mg","entries":1,"percentage":33.3},"Heavy":{"lower":40.0,"upper":46.0,"unit":"mg","entries":0,"percentage":0.0},"Light":{"lower":30.9,"upper":30.9,"unit":"mg","entries":2,"percentage":66.7},"Strong":{"lower":30.0,"upper":40.0,"unit":"mg","entries":0,"percentage":0.0}}}]},"salts":[{"title":"Dextroamphetamine phosphate","name":"phosphate","slug":"dextroamphetamine_phosphate","drawn":true},{"title":"Dextroamphetamine hemisaccharate","name":"hemisaccharate","slug":"dextroamphetamine_hemisaccharate","drawn":true},{"title":"Dextroamphetamine hemisulfate","name":"hemisulfate","slug":"dextroamphetamine_hemisulfate","drawn":true},{"title":"Dextroamphetamine adipate","name":"adipate","slug":"dextroamphetamine_adipate","drawn":true},{"title":"Dextroamphetamine hydrochloride","name":"hydrochloride","slug":"dextroamphetamine_hydrochloride","drawn":true}],"esters":[],"chirality":"absolute","stereo_type":null,"optical_activity":"( + )","stereoisomers":[],"lipinski":{"passes":true,"violations":0},"reagents":[],"atc":[{"code":"N","description":"Nervous system"},{"code":"N06","description":"Psychoanaleptics"},{"code":"N06B","description":"Psychostimulants, agents used for adhd and nootropics"},{"code":"N06BA","description":"Centrally acting sympathomimetics"},{"code":"N06BA02","description":"Dexamfetamine"}],"mesh":[{"name":"Central Nervous System Stimulants","id":"M0001063"},{"name":"Dopamine Uptake Inhibitors","id":"M0028098"}],"actives":[],"prodrugs":[{"name":"Benzphetamine","href":"/substance/benzphetamine"},{"name":"Clobenzorex","href":"/substance/clobenzorex"},{"name":"Lisdexamphetamine","href":"/substance/lisdexamphetamine"},{"name":"N-(L-Lysinamidyl)-3,4-methylenedioxyamphetamine","href":"/substance/n-%28l-lysinamidyl%29-3,4-methylenedioxyamphetamine"}],"codrug":false,"interactions":[{"target":"CYP2D6","mechanisms":["metabolism","inhibition","induction"],"partners":6,"contraindicated":1},{"target":"SLC6A2","mechanisms":["shared target"],"partners":2,"contraindicated":0},{"target":"SLC6A3","mechanisms":["shared target"],"partners":1,"contraindicated":0}],"mechanism":"The exact mechanism of amphetamines as a class is not known. Dextroamphetamine acts by preventing reuptake, increasing release, and stimulating reverse-transport of dopamine in synaptic clefts in the striatum. Newer evidence shows amphetamines may also alter the number of dopamine transporters in synaptic clefts.","side_effects":null,"effects":{"groups":[["Physical Effects",["Abnormal heartbeat","Appetite suppression","Dehydration","Dry mouth","Increased blood pressure","Increased heart rate","Increased libido","Restless legs","Shakiness","Stamina enhancement","Stimulation","Teeth grinding","Vasoconstriction"]],["Cognitive Effects",["Analysis enhancement","Cognitive euphoria","Compulsive redosing","Disinhibition","Ego inflation","Focus enhancement","Increased music appreciation","Mania","Motivation enhancement","Suggestibility suppression","Thought acceleration","Wakefulness"]]]},"usernotes":[{"user":"0xea","user_slug":"0xea","external":false,"note":{"substance":"Dextroamphetamine","composite":false,"routes":[{"name":"Oral","dosage":"2.5-20mg","onset":null,"comeup":null,"duration":null,"active":null},{"name":"Intravenous","dosage":"5mg","onset":null,"comeup":null,"duration":null,"active":null}],"dosages":[],"classes":["Stimulant"],"forms":["Sulfate"],"sources":["Dexamfetamine Sulfate 5mg tablets: Tentin"],"indications":["{xeff 'motivation suppression'} (executive dysfunction)","{xeff 'depression'}","{xeff 'sleepiness'}","{xeff 'cognitive dysphoria'}"],"effects":["{sev 'strong'} {xeff 'stimulation'}","clean {sev 'strong'} {xeff 'cognitive euphoria'}","{sev 'strong'} {xeff 'focus enhancement'}","{sev 'light'} {xeff 'vasoconstriction'}","{sev 'strong'} {xeff 'compulsive redosing'}","{xeff 'paranoia'}","{xeff 'delusion'} (paranoid, shadow police)"],"conditional_effects":[],"after_effects":[],"tolerance":[],"odor":[],"notes":[]}},{"user":"bonzi","user_slug":"bonzi","external":false,"note":{"substance":"Dextroamphetamine","composite":false,"routes":[{"name":"Oral","dosage":"2.5-30mg","onset":null,"comeup":null,"duration":null,"active":null}],"dosages":[],"classes":[],"forms":[],"sources":[],"indications":[],"effects":[],"conditional_effects":[],"after_effects":[],"tolerance":[],"odor":[],"notes":[]}}],"erowid":[],"reddit":[],"legal":[{"jurisdiction":"Australia","status":"Schedule 8","act":null,"refs":[9,10]},{"jurisdiction":"Brazil","status":"A3","act":null,"refs":[11]},{"jurisdiction":"Canada","status":"Prescription only / Schedule G (CDSA I)","act":null,"refs":[12]},{"jurisdiction":"Germany","status":"Anlage III","act":"Betäubungsmittelgesetz (BtMG)","refs":[]},{"jurisdiction":"United Kingdom","status":"Class B","act":"Misuse of Drugs Act 1971","refs":[]},{"jurisdiction":"United States","status":"Schedule II","act":"Controlled Substances Act","refs":[13,14]},{"jurisdiction":"European Union","status":"Prescription only","act":null,"refs":[15]},{"jurisdiction":"United Nations","status":"Schedule II psychotropic","act":"Convention on Psychotropic Substances 1971","refs":[]},{"jurisdiction":"Other","status":"SE: Förteckning II","act":null,"refs":[16]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Dextroamphetamine"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/5826"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q1706418"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB01576"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL612"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A4469"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=51-64-9"},{"source":"HMDB","url":"https://hmdb.ca/metabolites/HMDB0015516"},{"source":"KEGG","url":"https://www.kegg.jp/entry/C07884"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID8022907"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Dextroamphetamine"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/TZ47U051FI"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 5826, Dextroamphetamine. Accessed November 20, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/5826>https://pubchem.ncbi.nlm.nih.gov/compound/5826</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Dextroamphetamine. UNII: TZ47U051FI. Global Substance Registration System. Accessed November 20, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/TZ47U051FI>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/TZ47U051FI</a>","Green-Hernandez C, Singleton JK, Aronzon DZ. Primary Care Pediatrics. Lippincott Williams &amp; Wilkins. 1 January 2001. <a href='https://books.google.com/books?id=o43u_qWT4asC'>https://books.google.com/books?id=o43u_qWT4asC</a>","Adderall- dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate tablet. DailyMed. 27 February 2022. <a href='https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f22635fe-821d-4cde-aa12-419f8b53db81'>https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f22635fe-821d-4cde-aa12-419f8b53db81</a>","Mignot EJ. A practical guide to the therapy of narcolepsy and hypersomnia syndromes. Neurotherapeutics. October 2012; 9(4):739–752. PMID 23065655. <a href='https://doi.org/10.1007/s13311-012-0150-9'>https://doi.org/10.1007/s13311-012-0150-9</a>","Stahl SM. Prescriber&#39;s Guide: Stahl&#39;s Essential Psychopharmacology. Cambridge University Press. March 2017.","Lemke TL, Williams DA, Roche VF, Zito W. Foye&#39;s Principles of Medicinal Chemistry. Wolters Kluwer Health/Lippincott Williams &amp; Wilkins. 2013.","dextrostat (dextroamphetamine sulfate) tablet [Shire US Inc.]. DailyMed. August 2006. <a href='https://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=1645'>https://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=1645</a>","Therapeutic Goods (Poisons Standard—February 2023) Instrument 2022. Australian Government Federal Register of Legislation. 26 September 2022. <a href='https://www.legislation.gov.au/Series/F2022L01257'>https://www.legislation.gov.au/Series/F2022L01257</a>","Fuller K. ADHD Stimulant Prescribing Regulations &amp; Authorities in Australia &amp; New Zealand. AADPA. 20 February 2022. <a href='https://aadpa.com.au/adhd-stimulant-prescribing-regulations-in-australia-new-zealand/'>https://aadpa.com.au/adhd-stimulant-prescribing-regulations-in-australia-new-zealand/</a>","RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 31 March 2023. <a href='https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992'>https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992</a>","Product monograph brand safety updates. Health Canada. 6 June 2024. <a href='https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database/label-safety-assessment-update/product-monograph-brand-safety-updates.html'>https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database/label-safety-assessment-update/product-monograph-brand-safety-updates.html</a>","Dexedrine spansule- dextroamphetamine sulfate capsule, extended release. DailyMed. 10 January 2022. <a href='https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cc717b9b-22ea-4c60-a1d4-ee38a40bce78'>https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cc717b9b-22ea-4c60-a1d4-ee38a40bce78</a>","Xelstrym- dextroamphetamine patch, extended release. DailyMed. 6 January 2023. <a href='https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0862f02a-72a8-41cc-8845-57cf4974bb6f'>https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0862f02a-72a8-41cc-8845-57cf4974bb6f</a>","List of nationally authorised medicinal products : Active substance(s): dexamfetamine : Procedure No. PSUSA/00000986/202109. Ema.europa.eu. <a href='https://www.ema.europa.eu/documents/psusa/dexamfetamine-list-nationally-authorised-medicinal-products-psusa/00000986/202109_en.pdf'>https://www.ema.europa.eu/documents/psusa/dexamfetamine-list-nationally-authorised-medicinal-products-psusa/00000986/202109_en.pdf</a>","Attentin, Tablett 5 mg. FASS. 24 April 2026. <a href='https://fass.se/health/product/20110721000068/fass-text'>https://fass.se/health/product/20110721000068/fass-text</a>"],"sources":[{"source":"dosing","status":"ok","fetched_at":"2026-11-20 04:08:29","note":null},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 04:08:25","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 04:08:25","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 04:08:29","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 04:08:25","note":"hmdb.ca refused automated access to HMDB0015516"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 04:08:26","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 04:08:25","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 04:08:25","note":"no r/tripreports posts mention it"},{"source":"sider","status":"missing","fetched_at":"2026-11-20 04:08:25","note":"not in SIDER"},{"source":"structure","status":"ok","fetched_at":"2026-11-20 04:08:25","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 04:08:25","note":null}],"description":"Dextroamphetamine is a stimulant substance."}